David M Ota

Title: Innovations by David M Ota in Malignant Disease Treatment

Introduction

David M Ota is a notable inventor based in Houston, Texas, recognized for his contributions to the field of medical nutrition and cancer treatment. With a total of four patents to his name, Ota has focused on developing innovative formulations that aid in the detection and treatment of malignant diseases.

Latest Patents

Ota's latest patents include methods for the treatment of malignant disease in patients using total parenteral nutrition formulations. These formulations incorporate essential amino acids combined with either arginine or ornithine, aimed at detecting recurrent malignant disease. The formulations stimulate tumor-specific polyamine production more effectively than non-tumor related polyamine production. Furthermore, they have been shown to increase red blood cell putrescine levels in tumor-bearing rats, while nontumor-bearing rats do not exhibit similar reactions. Ota's patents also disclose methods for making and administering these formulations, as well as their use in preventing DFMO-induced toxicity.

Career Highlights

Ota is affiliated with the University of Texas System, where he has made significant strides in the field of medical research. His work has been instrumental in advancing the understanding of nutritional interventions in cancer treatment.

Collaborations

Ota has collaborated with esteemed colleagues such as Jaffer Ajani and Bruce Grossie, Jr., contributing to the development of innovative solutions in the medical field.

Conclusion

David M Ota's work exemplifies the intersection of nutrition and cancer treatment, showcasing the potential of innovative formulations in improving patient outcomes. His contributions continue to influence the field and pave the way for future advancements.